Zosano Pharma Corporation (ZSAN) Trading Down 8.8%
Zosano Pharma Corporation (NASDAQ:ZSAN)’s share price was down 8.8% during mid-day trading on Tuesday . The company traded as low as $0.57 and last traded at $0.62. Approximately 844,340 shares were traded during trading, a decline of 46% from the average daily volume of 1,549,974 shares. The stock had previously closed at $0.68.
Separately, ValuEngine upgraded shares of Zosano Pharma Corporation from a “strong sell” rating to a “sell” rating in a research report on Friday, September 1st.
Zosano Pharma Corporation (NASDAQ:ZSAN) last posted its quarterly earnings data on Thursday, November 9th. The biotechnology company reported ($0.20) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.05). sell-side analysts predict that Zosano Pharma Corporation will post -0.79 EPS for the current year.
In other news, Director Kenneth Greathouse acquired 50,000 shares of the stock in a transaction that occurred on Wednesday, November 15th. The shares were purchased at an average cost of $0.62 per share, for a total transaction of $31,000.00. Following the transaction, the director now directly owns 35,000 shares in the company, valued at approximately $21,700. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 2.95% of the company’s stock.
An institutional investor recently raised its position in Zosano Pharma Corporation stock. Northern Trust Corp boosted its position in Zosano Pharma Corporation (NASDAQ:ZSAN) by 591.4% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 79,234 shares of the biotechnology company’s stock after buying an additional 67,774 shares during the period. Northern Trust Corp owned approximately 0.20% of Zosano Pharma Corporation worth $112,000 as of its most recent SEC filing. 22.39% of the stock is owned by institutional investors and hedge funds.
Zosano Pharma Corporation Company Profile
Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability.
Receive News & Ratings for Zosano Pharma Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zosano Pharma Corporation and related companies with MarketBeat.com's FREE daily email newsletter.